Chasing non-existent “microRNAs” in cancer

MicroRNAs (miRNAs) are important regulators of gene expression whose dysregulation is widely linked to tumourigenesis, tumour progression and Epithelial-Mesenchymal Transition (EMT), a developmental process that promotes metastasis when inappropriately activated. However, controversy has emerged regarding how many functional miRNAs are encoded in the genome, and to what extent non-regulatory products of RNA degradation have been mis-identified as miRNAs. Central to miRNA function is their capacity to associate with an Argonaute (AGO) protein and form an RNA-Induced Silencing Complex (RISC), which mediates target mRNA suppression. We report that numerous "miRNAs" previously reported in EMT and cancer contexts, are not incorporated into RISC and are not capable of endogenously silencing target genes, despite the fact that hundreds of publications in the cancer field describe their roles. Apparent function can be driven through the expression of artificial miRNA mimics which is not necessarily reflective of any endogenous gene regulatory function. We present biochemical and bioinformatic criteria that can be used to distinguish functional miRNAs from mistakenly annotated RNA fragments.

Authors

Institutions

Publication Details

Journal
Oncogenesis
Published
2025-04-18
DOI
https://doi.org/10.1038/s41389-025-00550-9
Citations
6
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
5.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chasing non-existent “microRNAs” in cancer

B. Kate Dredge, Nicholas I. Warnock, Ayla Orang, Mélodie Migault et al.
6 citations
Oncogenesis
MicroRNA in disease regulation
5.62
article

Chasing non-existent “microRNAs” in cancer

B. Kate Dredge, Nicholas I. Warnock, Ayla Orang, Mélodie Migault, Cameron P. Bracken, Gregory J. Goodall, Katherine A. Pillman, Andrew G. Bert, Philip A. Gregory, Julie M Bracken
article en
6 citations

Abstract

MicroRNAs (miRNAs) are important regulators of gene expression whose dysregulation is widely linked to tumourigenesis, tumour progression and Epithelial-Mesenchymal Transition (EMT), a developmental process that promotes metastasis when inappropriately activated. However, controversy has emerged regarding how many functional miRNAs are encoded in the genome, and to what extent non-regulatory products of RNA degradation have been mis-identified as miRNAs. Central to miRNA function is their capacity to associate with an Argonaute (AGO) protein and form an RNA-Induced Silencing Complex (RISC), which mediates target mRNA suppression. We report that numerous "miRNAs" previously reported in EMT and cancer contexts, are not incorporated into RISC and are not capable of endogenously silencing target genes, despite the fact that hundreds of publications in the cancer field describe their roles. Apparent function can be driven through the expression of artificial miRNA mimics which is not necessarily reflective of any endogenous gene regulatory function. We present biochemical and bioinformatic criteria that can be used to distinguish functional miRNAs from mistakenly annotated RNA fragments.

OncogenesisVol. 14(1)
South Australia Pathology (AU), University of South Australia (AU), Centre for Cancer Biology (AU), The University of Adelaide (AU)
Royal Adelaide Hospital
Zero hunger
Openalex Percentile: Top 4%
MicroRNA in disease regulation
5.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.